Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Prostatic neoplasms and hypertrophy
ADR ID BADD_A03569
ADR Hierarchy
21      Reproductive system and breast disorders
21.04      Prostatic disorders (excl infections and inflammations)
21.04.02      Prostatic neoplasms and hypertrophy
Description Not Available
MedDRA Code 10036966
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D02003Selegiline hydrochloride
BADD_D02018Sildenafil
BADD_D02026Simvastatin
BADD_D02029Sitagliptin
BADD_D02047Sodium oxybate
BADD_D02053Sofosbuvir
BADD_D02058Sorafenib
BADD_D02100Sunitinib
BADD_D02104Tacrine hydrochloride
BADD_D02105Tacrolimus
BADD_D02106Tadalafil
BADD_D02113Tamsulosin
BADD_D02115Tapentadol
BADD_D02170Testosterone
BADD_D02171Testosterone cypionate
BADD_D02172Testosterone enanthate
BADD_D02173Testosterone propionate
BADD_D02174Testosterone undecanoate
BADD_D02192Thalidomide
BADD_D02224Tiotropium bromide
BADD_D02236Tofacitinib
BADD_D02237Tofacitinib citrate
BADD_D02241Tolcapone
BADD_D02257Trametinib
BADD_D02297Triptorelin
BADD_D02325Valdecoxib
BADD_D02331Valsartan
BADD_D02345Venetoclax
BADD_D02346Venlafaxine
BADD_D02348Verapamil
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages